A Novel Protocol to Differentiate Induced Pluripotent Stem Cells by Neuronal microRNAs to Provide a Suitable Cellular Model

Chemical Biology and Drug Design

Volumn 86, Issue 2, 2015, Pages 232-238

  Zare, Mehrak ^a,b   Soleimani, Masoud ^c   Akbarzadeh, Abolfazl ^d   Bakhshandeh, Behnaz ^e   Aghaee Bakhtiari, Seyed Hamid ^a   Zarghami, Nosratollah ^f,g  

^a STEM CELL TECHNOLOGY RESEARCH CENTER   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF TEHRAN   (Iran)

^f TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cellular model; iPS cell; miR 124; miR 128; neuronal differentiation

Indexed keywords

BETA TUBULIN; BRAIN DERIVED NEUROTROPHIC FACTOR; MICRORNA 124; MICROTUBULE ASSOCIATED PROTEIN 2; NEURON SPECIFIC ENOLASE; MICRORNA; MIRN124 MICRORNA, HUMAN; MIRN128 MICRORNA, HUMAN;

ARTICLE; CELL CULTURE; CLINICAL PROTOCOL; DEGENERATIVE DISEASE; DRUG SCREENING; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOCYTOCHEMISTRY; LENTIVIRINAE; NERVE CELL DIFFERENTIATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ADMINISTRATION AND DOSAGE; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; GENETIC TRANSDUCTION; GENETICS; INDUCED PLURIPOTENT STEM CELL; NERVE CELL; NEURAL STEM CELL; NEURODEGENERATIVE DISEASES; PATHOLOGY; PHYSIOLOGY; PLASMID; PRECLINICAL STUDY; PROCEDURES;

CELL DIFFERENTIATION; DRUG EVALUATION, PRECLINICAL; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICRORNAS; NEURAL STEM CELLS; NEURODEGENERATIVE DISEASES; NEURONS; PLASMIDS; TRANSDUCTION, GENETIC;

EID: 84947127773     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12485     Document Type: Article

References (31)

1. Ha T.Y., (2011) MicroRNAs in human diseases: from autoimmune diseases to skin, psychiatric and neurodegenerative diseases. Immune Netw; 11: 227-244.
2. Martino S., di Girolamo I., Orlacchio A., Datti A., (2009) MicroRNA implications across neurodevelopment and neuropathology. J Biomed Biotechnol; 2009: 654346.
3. Hafizi M., Atashi A., Bakhshandeh B., Kabiri M., Nadri S., Hosseini R.H., Soleimani M., (2013) MicroRNAs as markers for neurally committed CD133+/CD34+ stem cells derived from human umbilical cord blood. Biochem Genet; 51: 175-188.
4. Durnaoglu S., Genc S., Genc K., (2011) Patient-specific pluripotent stem cells in neurological diseases. Stem Cells Int; 2011: 212487.
5. Aguzzi A., Brandner S., Sure U., Ruedi D., Isenmann S., (1994) Transgenic and knock-out mice: models of neurological disease. Brain Pathol; 4: 3-20.
6. Goldman S.A., Nedergaard M., Windrem M.S., (2012) Glial progenitor cell-based treatment and modeling of neurological disease. Science; 338: 491-495.
7. Leeb C., Jurga M., McGuckin C., Moriggl R., Kenner L., (2010) Promising new sources for pluripotent stem cells. Stem Cell Rev; 6: 15-26.
8. Bongso A., Fong C.Y., Gauthaman K., (2008) Taking stem cells to the clinic: major challenges. J Cell Biochem; 105: 1352-1360.
9. Havasi P., Nabioni M., Soleimani M., Bakhshandeh B., Parivar K., (2013) Mesenchymal stem cells as an appropriate feeder layer for prolonged in vitro culture of human induced pluripotent stem cells. Mol Biol Rep; 40: 3023-3031.
10. Inoue H., Yamanaka S., (2011) The use of induced pluripotent stem cells in drug development. Clin Pharmacol Ther; 89: 655-661.
11. Mostoslavsky G., (2012) Concise review: the magic act of generating induced pluripotent stem cells: many rabbits in the hat. Stem Cells; 30: 28-32.
12. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L., (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol; 27: 275-280.
13. Patel M., Yang S., (2010) Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev; 6: 367-380.
14. Hafizi M., Bakhshandeh B., Soleimani M., Atashi A., (2012) Exploring the enkephalinergic differentiation potential in adult stem cells for cell therapy and drug screening implications. In Vitro Cell Dev Biol Anim; 48: 562-569.
15. Bakhshandeh B., Soleimani M., Hafizi M., Paylakhi S.H., Ghaemi N., (2012) MicroRNA signature associated with osteogenic lineage commitment. Mol Biol Rep; 39: 7569-7581.
16. Alejandro Lopez-Ramirez M., Nicoli S., (2013) Role of miRNAs and epigenetics in neural stem cell fate determination. Epigenetics; 9: 90-100.
17. Bakhshandeh B., Soleimani M., Paylakhi S.H., Ghaemi N., (2012) A microRNA signature associated with chondrogenic lineage commitment. J Genet; 91: 171-182.
18. Singh S.K., (2007) miRNAs: from neurogeneration to neurodegeneration. Pharmacogenomics; 8: 971-978.
19. Papagiannakopoulos T., Kosik K.S., (2009) MicroRNA-124: micromanager of neurogenesis. Cell Stem Cell; 4: 375-376.
20. Sanuki R., Onishi A., Koike C., Muramatsu R., Watanabe S., Muranishi Y., Irie S., et al,. (2011) miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression. Nat Neurosci; 14: 1125-1134.
21. Maiorano N.A., Mallamaci A., (2009) Promotion of embryonic cortico-cerebral neuronogenesis by miR-124. Neural Dev; 4: 40.
22. Deo M., Yu J.Y., Chung K.H., Tippens M., Turner D.L., (2006) Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev Dyn; 235: 2538-2548.
23. Krichevsky A.M., Sonntag K.C., Isacson O., Kosik K.S., (2006) Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells; 24: 857-864.
24. Cao X., Pfaff S.L., Gage F.H., (2007) A functional study of miR-124 in the developing neural tube. Genes Dev; 21: 531-536.
25. Evangelisti C., Florian M.C., Massimi I., Dominici C., Giannini G., Galardi S., Bue M.C., Massalini S., McDowell H.P., Messi E., Gulino A., Farace M.G., Ciafre S.A., (2009) MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J; 23: 4276-4287.
26. Bruno I.G., Karam R., Huang L., Bhardwaj A., Lou C.H., Shum E.Y., Song H.W., Corbett M.A., Gifford W.D., Gecz J., Pfaff S.L., Wilkinson M.F., (2011) Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay. Mol Cell; 42: 500-510.
27. Shi Z.M., Wang J., Yan Z., You Y.P., Li C.Y., Qian X., Yin Y., Zhao P., Wang Y.Y., Wang X.F., Li M.N., Liu L.Z., Liu N., Jiang B.H., (2012) MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. PLoS ONE; 7: e32709.
28. Purow B., (2011) The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma? J Neurooncol; 103: 429-436.
29. Koehler K.R., Tropel P., Theile J.W., Kondo T., Cummins T.R., Viville S., Hashino E., (2011) Extended passaging increases the efficiency of neural differentiation from induced pluripotent stem cells. BMC Neurosci; 12: 82.
30. Zinkel S., Gross A., Yang E., (2006) BCL2 family in DNA damage and cell cycle control. Cell Death Differ; 13: 1351-1359.
31. Martinez Y., Bena F., Gimelli S., Tirefort D., Dubois-Dauphin M., Krause K.H., Preynat-Seauve O., (2012) Cellular diversity within embryonic stem cells: pluripotent clonal sublines show distinct differentiation potential. J Cell Mol Med; 16: 456-467.